Statistical methods in epidemiology.ppt

RavinandanAPNandan 952 views 27 slides Aug 10, 2023
Slide 1
Slide 1 of 27
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27

About This Presentation

Statistical methods in epidemiology.-
Epidemiology
Incidence
Prevalence
Relative risk
Attributable risk


Slide Content

By:
Ravinandan AP
Department of Pharmacy Practice
Sree Siddaganga College of
Pharmacy, Tumkur
Statistical
Methods In
Epidemiology

Presentation Outlines….
1.Epidemiology
2.Incidence
3.Prevalence
4.Relative risk
5.Attributable risk

Epidemiology
Itisthestudyofdiseaseoccurrence
&transmissioninahuman
population.
Itfocusonthedistribution&
determinationofdisease.
Thebranchofmedicalsciencedealing
withthetransmissionandcontrolof
disease
Itmayalsobeconsideredasmethod
ofpublichealth-ascientificapproach
tostudyingdisease&health
problems.

Example for Epidemiology

Itconsistsofresearchmethods&
specificstrategiesforcounting&
calculatingtheoccurrence&riskof
disease.
Therefore,epidemiologicalstudiesof
druguseemploythesemethods&
statisticalmeasurestostudythe
occurrence&distributionofdruguse
&itsassociatedproblems.

Risk Assessment
Riskmeasuresareestimatedthat
describetheamountofrisk
associatedwithaparticular
exposureinasamplepopulation.
Riskestimatescanquantitatively
describetheriskassociatedwith
particularexposure & the
developmentorpreventionof
disease,&theycanquantifythe
associationbetweentheexposureto
aparticulartodrug&anADR.

Riskestimatedarepartofourdaily
lives.
Measuresofriskarecommunicated
topatientsvianewspapers,TV,and
theinternetdaily.
Riskmeasuresarecommunicatedto
GP’sviastudiespublishedin
medicaljournals.
Theseriskmeasuresbecome
importantintheclinicaldecision
makingprocessforbothpatients&
thepractitioners.

Prevalence
Itisdefinedasthenumberof
existingcasesofdisease(orany
outcome,exADR,druguse)ina
populationataparticularpointin
time.
number of existing cases in a
population
P=--------------------------------------------
total number of people in that
population

Example:1
OnJanuary1,2018SSCPhad
3000studentsenrolled.OnJanuary
1,2018,300studentsatSSCP
reporteddengue.
number of existing cases in a population
P=--------------------------------------------
total number of people in that population
P=300/3000=0.10or10%
Therefore,onJan1,2018,10%of
thestudentsatSSCPsufferedfrom
Dengue.
Inotherwords,theprevalenceof
dengueonJan1,2018,was10%

Prevalence = no. of cases /
population size
Prevalence can be measured in an
closed cohort or in an open
population.
Prevalence in cross-sectional.
“Old” cases and “new” cases are
counted in the numerator.
Can be measured at a particular
point (point prevalence) or over a
period (period prevalence).
Normally, when we say prevalence
we mean “point prevalence.”

Incidence
Itisdefinedasthenumberofnew
casesofdiseasethatdevelopina
populationatriskoveraspecified
timeperiod.
Itisusedtodeterminehowoftenthe
diseaseisoccurring.
Itistypicallydescribedaseither
cumulativeincidence(CI)oran
incidencerate(IR).

Cumulative Incidence (CI)
Cumulativeincidenceassumesthat
allofthesubjectswerefollowedfor
theentirestudyperiod.
CIdoesnotreflectstudydropoutsor
lossestofollow-up.
number of new cases disease during
given time
CI=--------------------------------------------
total population at risk

UsingSSCPcollege,inthefirstex-1
thetimeframeofJan1,2018,
throughDec31,2018,30students
developeddengue.
CI=30/3000-300=0.011or1.1%per
year.
ForthetimeperiodfromJan1,2018,
throughDec31,2018,1.1%ofstudents
atSSCPdevelopeddengue.Incidenceof
dengueinSSCPwas1.1%

Incidencemeasurestheriskof
developingthediseaseoroutcome
ofinterestinapopulationatrisk;
therefore,anysubjectswhocurrently
havethediseaseoroutcomeof
interestattheonsetofstudyperiod
are subtractedfrom the
denominator.

Incidence rate (IR)
Alsoreferredtoasincidencedensity
(ID).
Itisamoreaccuratemeansof
measuringdiseaseoccurrence.
IRtakesintoaccounttheactual
observationtimeofeachsubject
duringthestudyperiod,ratherthan
assumingthatallsubjectswere
followedfortheentireperiodoftime.

number of new cases
IR=---------------------------------------
total person –time of observation
in population at risk

Atoolusedtocalculateriskestimatesis
contingencytable.
Thesetablesareusedtoanalyzediscrete
data.
Incidencesandprevalenceareoften
reportedwithapopulationmultipliersuch
“permpeople”or“permperson-years.”
Toconvertarateorproportionto“perm
people,”simplymultiplyingbym.
Forexample,anincidencerateof
0.00877perperson-year=0.008770×
100,000=877per100,000person-years.

Definition of terms
Probability:istheproportions(%)of
timesaneventwouldoccurifan
observationwasrepeatedmany
times.
Risk:istheprobabilityofanevent
amongthoseexperiencingtheevent
dividedbythenumberwhocould
experienceit(atrisk)
Odds:probabilityofaneventdivided
bytheprobabilityoftheeventnot
happening

Relative Risk (RR)
RRisthelikelihoodof
developingdiseaseinthe
exposedgrouprelativetothe
unexposedgroup;itisa
measureofassociationbetween
theexposureandthedisease.
RR=CIexposed/
CIunexposed

RR can be estimated from a 2 X
2 contingency table.
Interpretation of RRRR Association
betweenexposure
&outcome
1 No association
<1 Negative association
/ Decreased risk
>1 Positive association
/
Increased risk

Attributable Risk (AR)
Itisalsocalledriskdifference(RD).
Isanothermeasureofriskusedin
studies.
Itprovidesinformationonthe
absoluteeffectoftheexposure.
Itdescribestheexcessriskof
diseaseintheexposedcompared
withthosewhowereunexposed.

ABSOLUTE RISK (AR)
Itistheprobabilitythatan
individualwillexperiencethe
specifiedoutcomeduringa
specifiedperiod.
Itliesintherange0to1,or0%
to100%.
Incontrasttocommonusage,
thewordriskmayreferto
adverseevents(suchas
myocardialinfarction),or
desirableevents(suchascure)

Absolute risk reduction (ARR)
Itistheabsolutedifference
inriskbetween the
experimentalandcontrol
groupsinatrial.
Itisusedwhentheriskin
thecontrolgroupexceeds
therisk

AR=CIexposed–
CIunexposed
Itallowstheinvestigatorto
determinehowmorbidity&
mortalityareaffectedby
removingexposure.

Attributable Risk percent
Theattributableriskcanthenbe
convertedtothe(AR%).
Itmakeseasiertointerpret.
AR%=
CIexposed-CIunexposedX100
CIexposed

THANK YOU